Home Euglucon 5mg Tablet — Glibenclamide for Type 2 Diabetes
Euglucon 5mg Tablet — Glibenclamide for Type 2 Diabetes – Available in Pakistan
Euglucon 5mg Tablet – Glibenclamide for Type 2 Diabetes Management – View Product Detail
Euglucon 5mg Tablet — Glibenclamide for Type 2 Diabetes – Available in Pakistan
Euglucon 5mg Tablet – Glibenclamide for Type 2 Diabetes Management – View Product Detail

Euglucon 5mg Tablet — Glibenclamide for Type 2 Diabetes

Euglucon 5mg Tablets contain Glibenclamide 5mg, a sulfonylurea oral hypoglycaemic agent for the management of type 2 diabetes mellitus. It stimulates pancreatic insulin secretion to lower blood glucose levels. This is a prescription-only antidiabetic medicine; hypoglycaemia risk requires regular blood sugar monitoring.

Sale price Rs. 192

Pay in 3 Installments of

Rs.

73

Availability: In stock SKU: DRM-RJ-0274
Tags: antidiabetic Pakistan blood sugar control Euglucon 5mg Glibenclamide 5mg oral hypoglycemic prescription diabetes medicine sulfonylurea 2 diabetes
Euglucon 5mg Tablet — Glibenclamide for Type 2 Diabetes – Available in Pakistan

Euglucon 5mg Tablet — Glibenclamide for Type 2 Diabetes

Rs. 192

Euglucon 5mg Tablet — Glibenclamide Sulfonylurea

Euglucon 5mg Tablets contain Glibenclamide 5mg, a second-generation sulfonylurea oral hypoglycaemic agent used for the management of type 2 diabetes mellitus. It stimulates the pancreatic beta cells to secrete insulin, helping to lower blood glucose levels.

This medicine requires a valid prescription from a licensed physician.

Clinical Uses

  • Management of type 2 diabetes mellitus when diet and exercise alone are insufficient
  • Blood glucose control in patients with residual pancreatic beta-cell function
  • May be used in combination with other oral antidiabetic agents under physician guidance

How It Works

Glibenclamide stimulates insulin secretion from pancreatic beta cells by closing ATP-sensitive potassium channels, causing depolarisation and calcium influx. This insulin-secretagogue mechanism lowers blood glucose levels effectively in type 2 diabetes.

Important Information

  • Risk of hypoglycaemia (low blood sugar) — monitor glucose levels regularly
  • Not for use in type 1 diabetes or diabetic ketoacidosis
  • Use with caution in elderly patients and those with renal or hepatic impairment
  • Do not skip meals while on this medication to avoid hypoglycaemia

Browse our General Medicines collection or explore all Tablets and Capsules at Derma.pk.

Usage & Benefits
  • Stimulates insulin secretion from pancreatic beta cells to lower blood glucose
  • Effective oral hypoglycaemic therapy for type 2 diabetes mellitus
  • Helps achieve glycaemic targets when diet and exercise are insufficient
  • Reduces long-term diabetes complications with adequate blood glucose control
  • Can be used as monotherapy or combined with other antidiabetic agents
  • Established sulfonylurea with a well-documented clinical profile
How To Use

Take tablets as prescribed by your physician, typically with or immediately after meals to reduce the risk of hypoglycaemia. Swallow with water. Do not skip meals while on Glibenclamide. Monitor blood glucose levels regularly and keep a fast-acting glucose source available in case of hypoglycaemic episodes. Do not self-adjust the dose. Report any episodes of low blood sugar to your physician.

FAQs

What is Euglucon 5mg used for?

Euglucon 5mg is prescribed for the management of type 2 diabetes mellitus in adults when blood glucose cannot be controlled adequately through diet and exercise alone.

Does Euglucon 5mg require a prescription?

Yes. Glibenclamide is a prescription-only medicine. A valid prescription from a licensed physician is required before dispensing.

What is the risk of hypoglycaemia with Euglucon 5mg?

Glibenclamide can cause hypoglycaemia (low blood sugar), particularly if meals are skipped or the dose is too high. Regular blood glucose monitoring, consistent meal timing, and keeping a glucose source available are important safety measures. Report hypoglycaemic episodes to your physician.